Your browser doesn't support javascript.
loading
Cysteine and hydrophobic residues in CDR3 serve as distinct T-cell self-reactivity indices.
Daley, Stephen R; Koay, Hui-Fern; Dobbs, Kerry; Bosticardo, Marita; Wirasinha, Rushika C; Pala, Francesca; Castagnoli, Riccardo; Rowe, Jared H; Ott de Bruin, Lisa M; Keles, Sevgi; Lee, Yu Nee; Somech, Raz; Holland, Steven M; Delmonte, Ottavia M; Draper, Debbie; Maxwell, Sandra; Niemela, Julie; Stoddard, Jennifer; Rosenzweig, Sergio D; Poliani, Pietro Luigi; Capo, Valentina; Villa, Anna; Godfrey, Dale I; Notarangelo, Luigi D.
Afiliación
  • Daley SR; Infection and Immunity Program, Monash Biomedicine Discovery Institute and Department of Biochemistry and Molecular Biology, Monash University, Melbourne, Australia. Electronic address: stephen.daley@monash.edu.
  • Koay HF; Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, Australia; Australian Research Council Centre of Excellence in Advanced Molecular Imaging, University of Melbourne, Melbourne, Australia.
  • Dobbs K; Laboratory of Clinical Immunology and Microbiology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Md.
  • Bosticardo M; Laboratory of Clinical Immunology and Microbiology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Md.
  • Wirasinha RC; Infection and Immunity Program, Monash Biomedicine Discovery Institute and Department of Biochemistry and Molecular Biology, Monash University, Melbourne, Australia.
  • Pala F; Laboratory of Clinical Immunology and Microbiology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Md.
  • Castagnoli R; Laboratory of Clinical Immunology and Microbiology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Md.
  • Rowe JH; Division of Hematology-Oncology, Boston Children's Hospital and Dana Farber Cancer Institute, Harvard Medical School, Boston, Mass.
  • Ott de Bruin LM; Division of Immunology, Boston Children's Hospital, Harvard Medical School, Boston, Mass.
  • Keles S; Division of Pediatric Immunology and Allergy, Meram Medical Faculty, Necmettin Erbakan University, Konya, Turkey.
  • Lee YN; Immunology Service, Edmond and Lily Safra Children's Hospital Sheba Medical Center, Tel Hashomer, Israel.
  • Somech R; Immunology Service, Edmond and Lily Safra Children's Hospital Sheba Medical Center, Tel Hashomer, Israel.
  • Holland SM; Laboratory of Clinical Immunology and Microbiology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Md.
  • Delmonte OM; Laboratory of Clinical Immunology and Microbiology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Md.
  • Draper D; Laboratory of Clinical Immunology and Microbiology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Md.
  • Maxwell S; Laboratory of Clinical Immunology and Microbiology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Md.
  • Niemela J; Immunology Service, Department of Laboratory Medicine, Clinical Center, National Institutes of Health, Bethesda, Md.
  • Stoddard J; Immunology Service, Department of Laboratory Medicine, Clinical Center, National Institutes of Health, Bethesda, Md.
  • Rosenzweig SD; Immunology Service, Department of Laboratory Medicine, Clinical Center, National Institutes of Health, Bethesda, Md.
  • Poliani PL; Department of Molecular and Translational Medicine, Pathology Unit, University of Brescia, Brescia, Italy.
  • Capo V; San Raffaele Telethon Institute for Gene Therapy, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) San Raffaele Scientific Institute, Milan, Italy.
  • Villa A; San Raffaele Telethon Institute for Gene Therapy, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) San Raffaele Scientific Institute, Milan, Italy; Istituto di Ricerca Genetica e Biomedica (IRGB), Consiglio Nazionale delle Ricerche (CNR), Milan Unit, Milan, Italy.
  • Godfrey DI; Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, Australia; Australian Research Council Centre of Excellence in Advanced Molecular Imaging, University of Melbourne, Melbourne, Australia.
  • Notarangelo LD; Laboratory of Clinical Immunology and Microbiology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Md. Electronic address: luigi.notarangelo2@nih.gov.
J Allergy Clin Immunol ; 144(1): 333-336, 2019 07.
Article en En | MEDLINE | ID: mdl-31053347
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Receptores de Antígenos de Linfocitos T / Linfocitos T / Regiones Determinantes de Complementariedad / Cisteína Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: J Allergy Clin Immunol Año: 2019 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Receptores de Antígenos de Linfocitos T / Linfocitos T / Regiones Determinantes de Complementariedad / Cisteína Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: J Allergy Clin Immunol Año: 2019 Tipo del documento: Article